The changing epidemiology of pulmonary hypertension: disease characteristics and clinical outcome over two decades of the swiss registry
P. Appenzeller (Zürich, Switzerland), M. Lichtblau (Zürich, Switzerland), C. Berlier (Zürich, Switzerland), J. Aubert (Lausanne, Switzerland), A. Azzola (Lucerne, Switzerland), J. Fellrath (Neuenburg, Switzerland), T. Geiser (Bern, Switzerland), F. Lador (Geneva, Switzerland), S. Pohle (St. Gallen, Switzerland), I. Opitz (Zurich, Switzerland), M. Schwerzmann (Bern, Switzerland), H. Stricker (Locarno, Switzerland), M. Tamm (Basel, Switzerland), S. Saxer (Zurich, Switzerland), S. Ulrich (Zurich, Switzerland)
Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Appenzeller (Zürich, Switzerland), M. Lichtblau (Zürich, Switzerland), C. Berlier (Zürich, Switzerland), J. Aubert (Lausanne, Switzerland), A. Azzola (Lucerne, Switzerland), J. Fellrath (Neuenburg, Switzerland), T. Geiser (Bern, Switzerland), F. Lador (Geneva, Switzerland), S. Pohle (St. Gallen, Switzerland), I. Opitz (Zurich, Switzerland), M. Schwerzmann (Bern, Switzerland), H. Stricker (Locarno, Switzerland), M. Tamm (Basel, Switzerland), S. Saxer (Zurich, Switzerland), S. Ulrich (Zurich, Switzerland). The changing epidemiology of pulmonary hypertension: disease characteristics and clinical outcome over two decades of the swiss registry. 3594
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: